Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Intraocular Position of Secondary Iris-Fixated IOLs in Aphakic Eyes

This study has been completed.
Information provided by (Responsible Party):
Michael Koss, Johann Wolfgang Goethe University Hospitals Identifier:
First received: October 15, 2008
Last updated: September 26, 2012
Last verified: September 2012

The purpose of this study is to evaluate the intraocular stability and safety of secondary iris-fixated IOLs in aphakic patients.


Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Intraocular Architecture of Secondary Implanted Anterior Chamber Iris-Fixated Lenses in Aphakic Eyes Evaluated With Anterior Segment Optical Coherence Tomography

Further study details as provided by Johann Wolfgang Goethe University Hospitals:

Primary Outcome Measures:
  • Intraocular IOL position [ Time Frame: 12-35 months postoperatively ] [ Designated as safety issue: No ]

Enrollment: 16
Study Start Date: September 2006
Study Completion Date: June 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Detailed Description:

18 eyes of 16 patients received secondary anteriorly iris-fixated intraocular lenses (IOLs) to correct for aphakia without capsular support, partly combined with anterior or complete pars plana vitrectomy. Primary outcome measurements included visual acuity (6m Snellen charts), central endothelium cell count (cECC) and postoperative intraocular position of the IOL assessed with anterior segment optical coherence tomography (OCT).


Ages Eligible for Study:   16 Years to 84 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with long standing Aphakia and eligibility for secondary IOL implantantion were retrospectively examined


Inclusion Criteria:

  • Patients with aphakia due to complicated cataract surgery, weakness in lens support (capsula, zonulae) Marfans´s syndrome

Exclusion Criteria:

  • Aphakia due to preexisting corneal, retinal o uveal disease, low endothelial cell count
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00773266

Zentrum für Augenheilkunde
Frankfurt, Hessen, Germany, 60590
Sponsors and Collaborators
Johann Wolfgang Goethe University Hospitals
  More Information

No publications provided

Responsible Party: Michael Koss, PI, Johann Wolfgang Goethe University Hospitals Identifier: NCT00773266     History of Changes
Other Study ID Numbers: MK-APHAKIA-08
Study First Received: October 15, 2008
Last Updated: September 26, 2012
Health Authority: Germany: Ethics Commission

Keywords provided by Johann Wolfgang Goethe University Hospitals:
Secondary IOL-Implantation
Iris-Fixated IOL
Anterior Segment OCT
Aphakia - secondary iris-fixated IOL position

Additional relevant MeSH terms:
Neoplasm Metastasis
Eye Diseases
Lens Diseases
Neoplastic Processes
Pathologic Processes processed this record on November 27, 2014